MatthewJohnWeissMD

General Surgery • New Hyde Park, NY

Hepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)

Deputy Physician-in-Chief & Surgical Director of Northwell Health Cancer Institute

Join to view full profile

Dr. Weiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Weiss' full profile

Already have an account?

Office
1111 Marcus Ave
New Hyde Park, NY 11042
Phone+1 516-321-2239

Summary

Dr. Matthew Weiss is a general surgeon in New Hyde Park, NY and is affiliated with the Northwell Health System. He received his medical degree from Sidney Kimmel Medical College and has been in practice 14 years. He was previously the chief of hepatopancreatobiliary surgery at Johns Hopkins. He specializes in hepatobiliary surgery, pancreas, and surgical oncology (other than breast) and is experienced in trauma and surgical critical care, surgical oncology (non-breast), colorectal surgery, general / gastrointestinal surgery, and hepatopancreatobiliary surgery.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 2010 - 2012
Johns Hopkins UniversityResidency, Surgery, 2003 - 2010
Massachusetts General HospitalPost-Doctoral Fellowship, 2005 - 2007
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2003

Certifications & Licensure

NY State Medical License 2010 - 2026
FL State Medical License 2018 - 2020
MD State Medical License 2012 - 2019
MA State Medical License 2005 - 2007
American Board of Surgery Surgery

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Fellow (FACS) American College of Surgeons

Clinical Trials

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Start of enrollment: 2013 Jan 01
COMPLETED
PHASE2

Publications & Presentations

PubMed

1 citations
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereota...
Colin S Hill, Rose Parkinson, Elizabeth M Jaffee, Elizabeth Sugar, Lei Zheng
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15
Textbook outcome in liver surgery for intrahepatic cholangiocarcinoma: defining predictors of an optimal postoperative course using machine learning.
Abdullah Altaf, Mujtaba Khalil, Miho Akabane, Zayed Rashid, Jun Kawashima
HPB. 2025-03-01
The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma.
Jun Kawashima, Yutaka Endo, Selamawit Woldesenbet, Mujtaba Khalil, Miho Akabane
Annals of Surgical Oncology. 2025-02-17

Journal Articles

Pancreatic Cancer Arising in the Remnant Pancreas Is Not Always a Relapse of the Preceding Primary
John L Cameron, Christopher L Wolfgang, Jin He, Matthew J Weiss, Ralph H Hruban, Michael Goggins, Nature
Single‐Cell Sequencing Defines Genetic Heterogeneity in Pancreatic Cancer Precursor Lesions
Kevin Waters, Jin He, Christopher L Wolfgang, Ralph H Hruban, Michael G Goggins, Matthew J Weiss, Justin Poling, The Journal of Pathology
Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant Chemotherapy
Alex B Blair, Joseph Herman, Martin Makary, John L Cameron, Amol Narang, Daniel Laheru, Christopher Wolfgang, Matthew J Weiss, Ammar A Javed, Jin He, Journal of gastrointestinal surgery
Blood Type as a Predictor of High-Grade Dysplasia and Associated Malignancy in Patients with Intraductal Papillary Mucinous Neoplasms
Martin A Makary, Michael Goggins, James Griffin, Katherine E Poruk, Jin He, Matthew J Weiss, John L Cameron, Christopher L Wolfgang, Journal of gastrointestinal surgery
Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) for Pancreatic Cancer. How I Do It
Matthew Weiss, Herbert J Zeh, Journal of gastrointestinal surgery
The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: An International Multi-Institutional Study
Bradley N Reames, Todd W Bauer, Michele M Gage, Shishir Maithel, Ryan C Fields, Matthew J Weiss, Timothy M Pawlik, Jin He, Journal of gastrointestinal surgery
Implications of the Pattern of Disease Recurrence on Survival Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Jin He, Ammar A Javed, John L Cameron, Alex B Blair, Elliot K Fishman, Matthew J Weiss, Ralph H Hruban, Christopher L Wolfgang, Annals of Surgical Oncology
Pancreaticoduodenectomy with en Bloc Vein Resection for Locally Advanced Pancreatic Cancer: A Case Series Without Venous Reconstruction
Bradley N Reames, Matthew J Weiss, Christopher L Wolfgang, Jin He, Elliot K Fishman, Michele M Gage, Annals of Palliative Medicine
Join now to see all

Lectures

BRAF V600E Mutation as a Negative Prognostic Determinant in Resected Colorectal Liver Metastases—Reply
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Press Mentions

Northwell Cancer Institute Only Center on Long Island to Develop Program to Treat Liver Tumors With Noninvasive Targeted Ultrasound BeamsNovember 20th, 2024
Targeting Cancer’s Achilles HeelSeptember 9th, 2022
BRCA2 Mutations Linked to Greater Risk for Pancreatic CancerApril 6th, 2017